Volume 14, Number 1—January 2008
THEME ISSUE
International Polar Year
Dispatch
Implementation and Effectiveness of Antiretroviral Therapy in Greenland
Nicolai Lohse*†
, Karin Ladefoged‡, and Niels Obel†1
, Karin Ladefoged‡, and Niels Obel†1
Table
Mortality rate per 1,000 person-years among HIV patients in Greenland and Denmark, 1995–2007*
| Variable | Greenland |
Denmark | ||
|---|---|---|---|---|
| All | Nuuk | Remote districts | ||
| Years | ||||
| 1995–1997 | 139 (81–239) | 178 (89–356) | 103 (43–247) | 96 (88–105) |
| 1998–2000 | 82 (47–144) | 62 (26–148) | 107 (51–225) | 29 (25–34) |
| 2001–2003 | 84 (50–141) | 107 (58–199) | 54 (20–144) | 25 (22–28) |
| 2004–2006 |
59 (35–99) |
43 (19–96) |
81 (41–162) |
24 (21–28) |
| Mortality rate ratio change per year, 1995–2006 | 0.91 (0.84–0.98) | 0.86 (0.77–0.96) | 0.96 (0.86–1.08) | 0.82 (0.80–0.84) |
| p value† | 0.014 | 0.006 | 0.533 | <0.001 |
*Ranges in parentheses are 95% confidence intervals.
†Test for trend.
1The Danish HIV Cohort Study: Departments of Infectious Diseases at Copenhagen University Hospitals Rigshospitalet (J. Gerstoft, N. Obel) and Hvidovre (G. Kronborg), Odense University Hospital (C. Pedersen), Aarhus University Hospitals, Skejby (C.S. Larsen) and Aalborg (G. Pedersen), Herning Hospital (A.L. Laursen), Helsingør Hospital (B. Kvinesdal), and Kolding Hospital (A. Møller).
Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.